1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Europe

Chronic Disease Analysis & Statistics 2021 - Europe

1-30 of 59 reports

Insulin Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 5000
  • September 2021
  • 175 pages

Major players in the insulin drugs market are Apidra, Eli Lilly, Humalog, Humulin, Insuman, Lantus, Levemir, Novo Nordisk, Novomix, and NovoRapid/Novolog. The global insulin drugs market is expected to ...

  • World
  • United States
  • Insulin
  • Diabetes
  • Industry analysis
  • Diabetes Prevalence
  • Labour Utilisation

Cardiovascular Medical Lasers Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 5000
  • September 2021
  • 175 pages

Major players in the cardiovascular medical lasers market are Boston Scientific Corp, Cardiovascular Systems, AngioDynamics, Royal Philips NV, and RA Medical Systems. The global cardiovascular medical ...

  • World
  • United Kingdom
  • Cardiology
  • Cardiovascular Disease
  • Industry analysis
  • Surgical Procedures Performed

Biosimilar Therapeutic Peptides Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 5000
  • September 2021
  • 175 pages

Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc., Amgen Inc., AstraZeneca PLC, GlaxoSmithKline (GSK), Novartis ...

  • World
  • United Kingdom
  • Biosimilar
  • Chronic Disease
  • Industry analysis
  • Drug Approval
  • Biosimilar Sales

Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth And Change To 2030

  • $ 5000
  • September 2021
  • 175 pages

Major players in the erythropoietin (EPO) market are Amgen Inc., Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion Inc, and LG Life Sciences Ltd. The global erythropoietin (EPO) market ...

  • World
  • Europe
  • Chronic Disease
  • Biopharmaceutical
  • Industry analysis

HDL Cholesterol Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • $ 3850
  • September 2021
  • 1 pages

HDL Cholesterol Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation This report is available by geographic ...

  • Europe
  • Northern Europe
  • Cholesterol
  • Diagnostics
  • Industry analysis

LDL Cholesterol Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • $ 3850
  • September 2021
  • 1 pages

LDL Cholesterol Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation This report is available by geographic ...

  • Europe
  • Northern Europe
  • Cholesterol
  • Diagnostics
  • Industry analysis

LDL Cholesterol Direct Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • $ 3850
  • September 2021
  • 1 pages

LDL Cholesterol Direct Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation This report is available by ...

  • Europe
  • Northern Europe
  • Cholesterol
  • Diagnostics
  • Industry analysis

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021

  • $ 2000
  • August 2021
  • 137 pages

Post Menopausal Osteoporosis (Musculoskeletal) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Drugs In Development, ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product, By Type Of Flow, By Application, By Design, By Region And Segment Forecasts, 2021 - 2028

  • $ 5950
  • August 2021
  • 131 pages

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product, By Type Of Flow (Pulsatile Flow, Continuous Flow), By Application, By Design, By Region, And Segment Forecasts, 2021 - ...

  • World
  • Germany
  • Cardiovascular Disease
  • Heart Failure
  • Industry analysis
  • Hospital Expenditure

Europe PCR for Respiratory Infection Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, Product Type, Infection Type, and End User

  • $ 3000
  • August 2021
  • 248 pages

The Europe PCR for respiratory infection diagnostics market is expected to reach US$ 2,432.46 million by 2028 from US$ 1,241.01 million in 2021; it is estimated to grow at a CAGR of 10.1% from 2021 to ...

  • Europe
  • Diagnostics
  • Respiratory Disease
  • Industry analysis
  • Diagnostic Revenue
  • Smoking Prevalence

Europe Home Sequential Compression Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type, Type, and Application

  • $ 3000
  • August 2021
  • 117 pages

The home sequential compression devices market in Europe is expected to grow from US$ 262.91 million in 2021 to US$ 405.94 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Venous ...

  • Europe
  • Healthcare
  • Compression Therapy
  • Industry analysis
  • Health Expenditure
  • Health Insurance Coverage

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology forecast- 2030

  • $ 4750
  • August 2021
  • 180 pages

‘Chronic Obstructive Pulmonary Disease (COPD)—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted ...

  • United States
  • Spain
  • Respiratory Disease
  • Industry analysis
  • Chronic Obstructive Pulmonary Disease Prevalence

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 218 pages

Allergic Rhinitis (Respiratory) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Drugs In Development, 2021, provides an overview ...

  • World
  • China
  • Respiratory Disease
  • Allergy Drug
  • Industry analysis
  • Pharmaceutical Registrations
  • Medicine Use

Peanut Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provides an overview of the ...

  • World
  • United Kingdom
  • Allergy
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Wearable Injectors Market by Product Type, Therapy, Technology, Care Setting - Global Forecast to 2026

  • $ 4950
  • July 2021
  • 194 pages

The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors ...

  • World
  • United States
  • Chronic Disease
  • Therapy
  • Industry analysis
  • Chronic Disease Prevalence
  • Diabetes Prevalence

Europe Arrythmia Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type, Application, and End User

  • $ 3000
  • July 2021
  • 114 pages

The arrythmia monitoring devices market in Europe is expected to grow from US$ 1,739.79 million in 2021 to US$ 2,638.61 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028. Growth ...

  • Europe
  • Cardiovascular Disease
  • Industry analysis
  • Health Expenditure
  • Cause-Specific Mortality Rate

Live Cell Imaging Global Market Report 2021: COVID-19 Growth And Change

  • $ 5000
  • July 2021
  • 175 pages

Major players in the live cell imaging market are Leica Microsystems, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare, Carl Zeiss Meditec AG, Becton Dickinson and Company, ...

  • World
  • United States
  • Drug Development
  • Laboratory
  • Industry analysis
  • Cancer Incidence
  • Chronic Disease Prevalence

2021-2025 Global Respiratory Disease Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for Suppliers

  • $ 7500
  • October 2021
  • 1 pages

2021-2025 Global Respiratory Disease Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Assays, Emerging Technologies and Trends, Instrumentation ...

  • World
  • Europe
  • Respiratory Disease
  • Industry analysis

2021 France Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 1500
  • July 2021
  • 1 pages

2021 France Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis About ...

  • France
  • Respiratory Disease
  • Molecular Diagnostics
  • Industry analysis

2021 Germany Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 1500
  • July 2021
  • 1 pages

2021 Germany Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis About ...

  • Germany
  • Respiratory Disease
  • Molecular Diagnostics
  • Industry analysis

2021 Italy Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 1500
  • July 2021
  • 1 pages

2021 Italy Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis About ...

  • Italy
  • Respiratory Disease
  • Molecular Diagnostics
  • Industry analysis

2021 Spain Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 1500
  • July 2021
  • 1 pages

2021 Spain Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis About ...

  • Spain
  • Respiratory Disease
  • Molecular Diagnostics
  • Industry analysis

2021 UK Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 1500
  • July 2021
  • 1 pages

2021 UK Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis About ...

  • United Kingdom
  • Respiratory Disease
  • Molecular Diagnostics
  • Industry analysis

EUROPE BLOOD FLOW MEASUREMENT DEVICES MARKET FORECAST 2021-2028

  • $ 1250
  • September 2021
  • 114 pages

KEY FINDINGS The Europe blood flow measurement devices market is anticipated to register a CAGR of 8.44% during the forecast period, 2021-2028. Cardiovascular disease (CVD) is responsible for around 3.9 ...

  • Europe
  • Healthcare
  • Chronic Disease
  • Industry analysis
  • Medical Devices Sales
  • Chronic Disease Prevalence

EUROPE ECG EQUIPMENT MARKET FORECAST 2021-2028

  • $ 1250
  • September 2021
  • 154 pages

KEY FINDINGS The Europe ECG equipment market growth is estimated to progress at a CAGR of 5.72% during the forecast period, 2021-2028. The surging aging population and favorable regulations for ECG products ...

  • Europe
  • France
  • Cardiovascular Disease
  • Industry analysis
  • Cause-Specific Mortality Rate

EUROPE X-RAY DETECTOR MARKET FORECAST 2021-2028

  • $ 1250
  • September 2021
  • 150 pages

KEY FINDINGS The Europe X-ray detector market is anticipated to record a CAGR of 6.28% during the forecasted period of 2021 to 2028. Some of the key factors, like the rising cases of accidents and injuries, ...

  • Europe
  • Russia
  • Chronic Disease
  • Healthcare IT
  • Industry analysis
  • Chronic Disease Prevalence

EUROPE NASAL SPRAY MARKET FORECAST 2021-2028

  • $ 1250
  • August 2021
  • 170 pages

KEY FINDINGS The Europe nasal spray market is projected to register a CAGR of 9.27% during the forecast period, 2021-2028. In Europe, lung cancer is becoming the leading cause of death. Also, there has ...

  • Europe
  • Russia
  • Respiratory Disease
  • Lung Cancer
  • Industry analysis
  • Mortality Rate
  • Asthma Prevalence

EUROPE CARTILAGE DEGENERATION MARKET FORECAST 2021-2028

  • $ 1250
  • August 2021
  • 170 pages

KEY FINDINGS The Europe cartilage degeneration market is projected to grow with a CAGR of 4.41% over the estimated years of 2021 to 2028. Leading factors fueling the regional market’s growth include ...

  • Europe
  • France
  • Research And Development
  • Sport Practice
  • Industry analysis

EUROPE COUGH SYRUP MARKET FORECAST 2021-2028

  • $ 1250
  • August 2021
  • 144 pages

KEY FINDINGS The Europe cough syrup market is evaluated to project a CAGR of 2.79% over the forecasted years of 2021 to 2028. The market growth of the region is facilitated by chief factors such as the ...

  • Europe
  • Italy
  • Respiratory Disease
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Mortality Rate

EUROPE NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028

  • $ 1250
  • July 2021
  • 169 pages

KEY FINDINGS The Europe neurovascular devices / interventional neurology market growth is anticipated to progress at a CAGR of 4.87% during the forecast period, 2021-2028. The surging prevalence of neurovascula ...

  • Europe
  • Germany
  • Stroke
  • Neurology
  • Industry analysis
  • Mortality Rate

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on